Article in Science advances, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 2 of them syntheses that pooled it.
0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 2 pooled it
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
11 citing papers in PubMed, 2 syntheses or guidelines pooled it, 13 citations in OpenAlex.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
19 authors at 4 institutions in 1 country.
Lawrence HuangLaboratory for Accelerated Vascular Research, Department of Surgery, University of California San Francisco, San Francisco, CA 94143, USA.ORCID 0000-0001-9074-4510
Feng ChengLaboratory for Accelerated Vascular Research, Department of Surgery, University of California San Francisco, San Francisco, CA 94143, USA.ORCID 0000-0001-5672-5578
Xuetao ZhangLaboratory for Accelerated Vascular Research, Department of Surgery, University of California San Francisco, San Francisco, CA 94143, USA.
Jacek ZielonkaFree Radical Research Laboratory, Department of Biophysics, Medical College of Wisconsin, Milwaukee, WI 53226, USA.ORCID 0000-0002-2524-0145
Matthew A NystoriakDepartment of Pharmacology, University of California, Davis, Davis, CA 95616, USA.ORCID 0000-0001-8872-158X
Weiwei XiangLaboratory for Accelerated Vascular Research, Department of Surgery, University of California San Francisco, San Francisco, CA 94143, USA.ORCID 0000-0002-3131-7970
Kunal RaygorLaboratory for Accelerated Vascular Research, Department of Surgery, University of California San Francisco, San Francisco, CA 94143, USA.ORCID 0000-0002-5517-7706
Shaoxun WangLaboratory for Accelerated Vascular Research, Department of Surgery, University of California San Francisco, San Francisco, CA 94143, USA.
Aditya LakshmananLaboratory for Accelerated Vascular Research, Department of Surgery, University of California San Francisco, San Francisco, CA 94143, USA.ORCID 0000-0002-6927-1066
Weiya JiangLaboratory for Accelerated Vascular Research, Department of Surgery, University of California San Francisco, San Francisco, CA 94143, USA.
Sai YuanLaboratory for Accelerated Vascular Research, Department of Surgery, University of California San Francisco, San Francisco, CA 94143, USA.ORCID 0000-0002-4089-5780
Kevin S HouLaboratory for Accelerated Vascular Research, Department of Surgery, University of California San Francisco, San Francisco, CA 94143, USA.
Jiayi ZhangLaboratory for Accelerated Vascular Research, Department of Surgery, University of California San Francisco, San Francisco, CA 94143, USA.
Xitao WangLaboratory for Accelerated Vascular Research, Department of Surgery, University of California San Francisco, San Francisco, CA 94143, USA.
Arsalan U SyedDepartment of Pharmacology, University of California, Davis, Davis, CA 95616, USA.
Matea JuricFree Radical Research Laboratory, Department of Biophysics, Medical College of Wisconsin, Milwaukee, WI 53226, USA.ORCID 0000-0001-5031-8285
Takamune TakahashiDivision of Nephrology and Hypertension, Vanderbilt University Medical Center, Nashville, TN 37232, USA.ORCID 0000-0002-4841-2499
Manuel F NavedoDepartment of Pharmacology, University of California, Davis, Davis, CA 95616, USA.ORCID 0000-0001-6864-6594
Rong A WangLaboratory for Accelerated Vascular Research, Department of Surgery, University of California San Francisco, San Francisco, CA 94143, USA.ORCID 0000-0001-7882-2475
University of California, San Francisco · USUniversity of California, Davis · USMedical College of Wisconsin · USVanderbilt University Medical Center · US
Funding
Coupling of Vascular Cav1.2 Channels In Health & DiseaseR01HL121059 · NHLBI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI NAVEDO, MANUEL F · 2015 to 2024
$4.5M
Notch Signaling in Mouse Arterial-Venous SpecificationR01HL075033 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI WANG, RONG · 2005 to 2015
$3.7M
Calcium Sparklets-Induced Vascular Dysfunction During DiabetesR01HL098200 · NHLBI · UNIVERSITY OF WASHINGTON · PI NAVEDO, MANUEL F · 2010 to 2019
$3.5M
Regulation of Coronary Blood FlowR01HL142710 · NHLBI · UNIVERSITY OF LOUISVILLE · PI NYSTORIAK, MATTHEW A · 2018 to 2022
$3.1M
Cerebral Vascular Smooth Muscle Dysfunction in Alzheimer's DiseaseR01HL149127 · NHLBI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI NAVEDO, MANUEL F · 2019 to 2022
$2.7M
cAMP signaling in vascular smooth muscle in health and diseaseR01HL161872 · NHLBI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI NAVEDO, MANUEL F · 2022 to 2025
$2.6M
Molecular Pathogenesis of Brain Arteriovenous MalformationR01NS067420 · NINDS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI WANG, RONG · 2010 to 2018
$2.3M
Molecular Pathogenesis of Hereditary Hemorrhagic TelangiectasiaR01NS113429 · NINDS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI WANG, RONG · 2020 to 2024
$2.3M
Molecular pathogenesis of brain arteriovenous malformationR56NS067420 · NINDS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI WANG, RONG · 2013 to 2013
Mechanisms underlying arteriovenous malformations (AVMs) are poorly understood. Using mice with endothelial cell (EC) expression of constitutively active Notch4 (Notch4*
Indexed as
Arteriovenous MalformationsHydrogen PeroxideNitric Oxide Synthase Type IIIAnimalsArteriesMiceNitric Oxide SynthaseNitroarginineHydrogen PeroxideNitric Oxide SynthaseNitric Oxide Synthase Type IIINitroarginine
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Nitric oxide synthase and reduced arterial tone contribute to arteriovenous malformation. · full record | OpenQuestion